Canine Atopic Dermatitis

Canine atopic dermatitis.

This study will evaluate the efficacy of a new treatment for canine atopic dermatitis.

Dog is at least 12 months of age and weighs at least 3 kgs or 6.6 lb
Dog is in overall good health and any underlying disease is stable
Dog has moderate pruritus, meets the minimum scores required for the study, and has a clinical diagnosis of atopic dermatitis
Dog has undergone all screening diagnostics which have ruled-out differential diagnoses
Owner agrees to maintain dog on an approved flea preventative for the duration of the study
Owner agrees to maintain dog on the same diet for the duration of the study
Dog does not have evidence of overt superficial or deep microbial skin infection (i.e. bacterial pyoderma or Malassezia dermatitis) at the time of study enrollment
Only one dog per household may be enrolled in this study
Owner is willing to comply with the study visit schedule and complete study-related activities

Dog is pregnant, lactating, or intended for use as a breeding animal
Dog is too aggressive or non-compliant to complete screening
Dog has evidence of malignant neoplasia, uncontrolled hypothyroidism, rickettsial disease, or
other condition that could affect immune function
Dog has evidence of fleas, ticks, mites, or other ectoparasites at the time of study enrollment
Dog is receiving or should be receiving systemic antimicrobial therapy for bacterial or fungal
dermatitis
Dog requires or is scheduled for vaccinations during the study
Dog does not meet minimum washout periods for excluded medications or minimal use or
frequency of use guidelines for conditionally approved medications
Dog had intradermal allergen testing less than 8 weeks prior to screening
Dog is owned by clinic personnel
Dog is currently enrolled in another clinical trial

6 visits over 112 days.

All study-related costs are covered by the sponsor.